This tirzepatide L-carnitine dosage chart explains typical titration steps, vial sizes, and safety notes for compounded GLP-1 weight loss plans in the US.
A tirzepatide L-carnitine dosage chart is a week-by-week titration schedule that lists how many milligrams of tirzepatide you inject and how much L-carnitine is mixed into that same vial by a compounding pharmacy. The tirzepatide part follows a fixed step-up pattern, while the L-carnitine part is not standardized and changes from one pharmacy to the next. Tirzepatide with L-carnitine is not FDA-approved as a combined product in the United States.
Tirzepatide Titration Steps Most Prescribers Follow
The tirzepatide portion of a compounded blend normally mirrors the FDA-approved Zepbound and Mounjaro schedule. Doses step up no more often than every four weeks, and 15 mg per week is the maximum approved dose.
| Weeks | Weekly tirzepatide dose | What to expect |
|---|---|---|
| 1-4 | 2.5 mg | Starting dose; mainly to test tolerance |
| 5-8 | 5 mg | First dose with measurable appetite effects |
| 9-12 | 7.5 mg | Common maintenance range for many patients |
| 13-16 | 10 mg | Used when weight loss plateaus |
| 17-20 | 12.5 mg | Step-up before the ceiling dose |
| 21+ | 15 mg | Maximum approved weekly dose |
Most people searching for a tirzepatide dosage chart for weight loss are looking for exactly this ladder. A prescriber may hold a dose longer than four weeks when nausea, constipation, or fatigue has not settled yet.
Where L-Carnitine Fits in the Blend
L-carnitine is an amino acid derivative sold as an oral supplement, typically in 500 mg to 2,000 mg daily doses. Compounding pharmacies add it to tirzepatide vials because it is marketed as supporting fat metabolism and because it may reduce injection-site irritation.
- Common ratio: roughly 100 mg to 200 mg of L-carnitine per mL, alongside 5 mg/mL to 20 mg/mL of tirzepatide.
- What the evidence shows: there are no large head-to-head human trials proving the blend produces more weight loss than tirzepatide alone.
- What it does not change: the tirzepatide milligrams still drive the titration schedule.
A tirzepatide l carnitine dosage chart is a tracking tool, not a prescription. Two pharmacies can label the same 2.5 mg dose with different liquid volumes and different syringe units.
How to Read the Math on Your Vial
Compounded tirzepatide ships in multi-dose vials, and concentration depends on how much bacteriostatic water the pharmacy used. A tirzepatide 30 mg vial dosage chart changes the units per injection, not the milligrams you receive.
| Vial size | Concentration | Units for 2.5 mg | Units for 5 mg |
|---|---|---|---|
| 10 mg / 1 mL | 10 mg/mL | 25 units | 50 units |
| 20 mg / 2 mL | 10 mg/mL | 25 units | 50 units |
| 30 mg / 3 mL | 10 mg/mL | 25 units | 50 units |
| 30 mg / 2 mL | 15 mg/mL | about 17 units | about 33 units |
These figures assume a U-100 insulin syringe, where 100 units equals 1 mL. Always confirm unit math with your pharmacist before drawing a dose, because a misread concentration is the most common cause of accidental overdose.
Single-Agent vs Compounded Blend
| Feature | Zepbound / Mounjaro | Tirzepatide + L-carnitine |
|---|---|---|
| FDA approval | Approved for weight loss and type 2 diabetes | Not approved as a combination |
| Standardization | Fixed, pre-filled pens | Varies by pharmacy |
| Dosing | 2.5 mg to 15 mg weekly | Same tirzepatide ladder plus variable L-carnitine |
| Availability | Retail and mail-order pharmacies | Compounding pharmacies only |
| Cost | Insurance dependent | Usually cash-pay |
Compounded tirzepatide can only be prepared legally under specific conditions, and FDA rules tightened after the tirzepatide shortage resolved. Confirm the current status with your prescriber before paying for a vial.
Safety, Side Effects, and What to Confirm First
- Common effects: nausea, vomiting, diarrhea, constipation, burping, fatigue, and injection-site reactions.
- Serious risks: pancreatitis, gallbladder disease, dehydration, and low blood sugar when used with insulin or sulfonylureas.
- L-carnitine effects: stomach upset, a fishy body odor at high doses, and rare seizure reports in people with seizure disorders.
- Do not use: during pregnancy, or with a personal or family history of medullary thyroid cancer or MEN2.
Discussion of cagrilintide with tirzepatide dosage belongs to investigational research, not routine weight-loss care. Likewise, people researching tissue recovery sometimes hunt for a bpc-157 dosage chart by weight, but no human dosing standard exists for that peptide either.
Bring your vial label and syringe to your prescriber or pharmacist before changing a dose, and keep scheduled follow-up labs. A dosage chart is a reference point, and your clinician decides what is safe for you.
RELATED PEPTIDE TOPICTirzepatide peptideFrequently Asked Questions
What is the starting dose of tirzepatide with L-carnitine?
The tirzepatide portion almost always starts at 2.5 mg once weekly for four weeks, matching the FDA-approved Zepbound and Mounjaro schedule. The L-carnitine amount in that same injection depends entirely on the compounding pharmacy. Follow the written instructions from your prescriber rather than a generic chart.
Is compounded tirzepatide with L-carnitine FDA-approved?
No. Tirzepatide alone is FDA-approved as Mounjaro for type 2 diabetes and Zepbound for weight loss, but the combination with L-carnitine is not FDA-approved. Compounded versions are not reviewed for safety, effectiveness, or quality the way brand products are.
Does L-carnitine help with weight loss on tirzepatide?
There is no large human trial showing that adding L-carnitine to tirzepatide produces more weight loss than tirzepatide alone. L-carnitine is studied mainly for energy metabolism and muscle recovery. Any weight change on a compounded blend is most likely driven by the tirzepatide dose.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.